Keith Regnante Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Regnante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Regnante. Keith Regnante is a Chief Financial Officer in Wave Life Sciences Ltd. ($WVE) and a Chief Financial Officer in Keros Therapeutics, Inc. ($KROS).
Address: C/O WAVE LIFE SCIENCES LTD., 733 CONCORD AVE. CAMBRIDGE 02138 MA
Companies in which Keith Regnante is an Insider
Keros Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Regnante: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Wave Life Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Regnante: Chief Financial Officer
Holdings: 29,186 shares
Current Value: $842,016
Latest Transaction: Mar 11 2019
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Keith Regnante
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 70.93 | 49,150 | 3,486,210 | 49,150 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 133,622 | 2,137,952 | 133,622 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 18,430 | 294,880 | 18,430 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 133,622 | 2,137,952 | 133,622 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 18,430 | 294,880 | 18,430 | |
| Mar 11 2019 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Grant | A | 0.00 | 13,500 | 0 | 29,186 | 15.7 K to 29.2 K (+86.06 %) |
| Feb 21 2019 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Sell | S | 36.84 | 1,298 | 47,818 | 15,686 | 17 K to 15.7 K (-7.64 %) |